Biovotion
Biovotion has developed an accurate, wearable sensing technology, that allows for medical-quality vital sign monitoring (VSM) in daily life. The platform combines medical-quality VSM with design, wearability, convenience, and prices of the consumer market. The system (multi-sensor platform plus sophisticated algorithms) is intergrated into cloud infrastructures to provide users with data on par with standard hospital systems and can be stepwise expanded with additional physiological parameters. Current parameters include heart rate, blood oxygenation, blood perfusion, temperature and movement/activity. The first VSM generation is also expected to include heart rate variability, respiratory rate, energy expenditure, and sleep and stress monitoring. The management team is internationally recognised for its expertise in wearable monitoring. The company holds a broad IP portfolio.
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Biovotion use?+
We have not yet detected technologies for Biovotion.
What industry is Biovotion in?+
Biovotion operates in the Diabetes industry.
Where is Biovotion based?+
Biovotion is headquartered in Switzerland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026